CN215128552U - SMD OSAHS detects treatment device - Google Patents
SMD OSAHS detects treatment device Download PDFInfo
- Publication number
- CN215128552U CN215128552U CN202022828389.2U CN202022828389U CN215128552U CN 215128552 U CN215128552 U CN 215128552U CN 202022828389 U CN202022828389 U CN 202022828389U CN 215128552 U CN215128552 U CN 215128552U
- Authority
- CN
- China
- Prior art keywords
- detection
- patch
- treatment
- osahs
- data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000001797 obstructive sleep apnea Diseases 0.000 title claims abstract description 34
- 238000001514 detection method Methods 0.000 claims abstract description 48
- 238000013186 photoplethysmography Methods 0.000 claims abstract description 38
- 230000000638 stimulation Effects 0.000 claims abstract description 38
- 210000003205 muscle Anatomy 0.000 claims abstract description 24
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 15
- 210000001169 hypoglossal nerve Anatomy 0.000 claims abstract description 5
- 239000000853 adhesive Substances 0.000 claims description 18
- 230000001070 adhesive effect Effects 0.000 claims description 18
- 238000001914 filtration Methods 0.000 claims description 12
- 230000005540 biological transmission Effects 0.000 claims description 8
- 230000009471 action Effects 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 2
- 230000008901 benefit Effects 0.000 abstract description 4
- 230000000451 tissue damage Effects 0.000 abstract description 4
- 231100000827 tissue damage Toxicity 0.000 abstract description 4
- 238000000034 method Methods 0.000 description 8
- 210000005036 nerve Anatomy 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 208000008784 apnea Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 210000002569 neuron Anatomy 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000005424 photoluminescence Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010021079 Hypopnoea Diseases 0.000 description 3
- 206010041235 Snoring Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000002457 bidirectional effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 230000036982 action potential Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000018875 hypoxemia Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000010801 machine learning Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 201000002282 venous insufficiency Diseases 0.000 description 2
- 206010006322 Breath holding Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 238000007418 data mining Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Images
Landscapes
- Electrotherapy Devices (AREA)
Abstract
The utility model discloses a SMD OSAHS detects treatment device, include: the patch comprises a patch body, wherein a detection device and a treatment device are arranged on the inner side of the patch body; the patch body is stuck outside the skin of the tongue chin genioglossus muscle of the neck of the human body; the detection device is used for collecting photoplethysmography signals when a human body is in a sleep state and generating electrical stimulation driving signals based on the treatment threshold range of the photoplethysmography signals; the treatment device is coupled with the detection device and releases the Lilly waveform to electrically stimulate the hypoglossal nerve branch innervating the genioglossus muscle after receiving the electric stimulation driving signal. The utility model adopts Lilly waveform, which effectively reduces muscle tissue damage; the percutaneous genioglossus muscle electrical stimulation therapy is realized, and the percutaneous genioglossus muscle electrical stimulation therapy has the advantages of small volume, light weight, simplicity and convenience in operation and the like, and is high in patient compliance and wide in applicable population.
Description
Technical Field
The utility model relates to the field of medical equipment, especially, relate to a SMD OSAHS detects treatment device.
Background
Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS) is a Sleep disordered breathing disease with Apnea or Hypopnea caused by collapse and obstruction of the soft tissues of the upper respiratory tract during Sleep. OSAHS patients are clinically characterized by inertial snoring (non-benign snoring) during sleep, frequent breath holding, wakening, restless sleep, dizziness, weakness in the morning, inattention, memory decline and the like, and diseases such as hypoxemia and the like are caused by insufficient ventilation during sleep. Modern medical research shows that OSAHS causes damage to cardiovascular systems, metabolic disorder and cognitive dysfunction, is a source disease of chronic diseases such as heart disease, hypertension, diabetes, dementia and the like, and is listed as one of major diseases threatening human health by International health organization of United nations. The incidence of OSAHS is as high as 6% -7% of the population, and Polysomnography (PSG) performed on OSAHS patients is the gold standard for diagnosis of OSAHS at present.
The inventor of the present application finds that the current clinical treatment means of unidirectional pulse waves (electrical stimulation treatment) mainly focuses on five categories of risk factor reduction, drug treatment, continuous positive airway pressure, oral appliances and draping soft palate plasty. The OSAHS treatment scheme known in the market at present is mostly operation treatment except drug treatment and CPAP, but conservative treatment methods which are prone to patients are adopted, but the treatment methods are generally low in comfort level and greatly affect the sleep quality of the patients, meanwhile, the operation treatment has large wound on the patients, and the drug treatment has certain side effects and is not suitable for the old people. And the pressure value of the CPAP is not easy to adjust, so that the CPAP is not suitable for people without medical basic knowledge to use at home.
SUMMERY OF THE UTILITY MODEL
The embodiment of the application provides a SMD OSAHS detects treatment device, has solved OSAHS detection treatment among the prior art and has influenced sleep treatment, is unsuitable for the technical problem who uses at home, utilizes SMD to realize genioglossus muscle electro photoluminescence therapy, has realized satisfying advantages such as small, light in weight, easy operation, can use for a long time and do not influence sleep.
The embodiment of the application provides a SMD OSAHS detects treatment device, includes: the patch comprises a patch body, wherein a detection device and a treatment device are arranged on the inner side of the patch body;
the patch body is stuck to the outer part of the skin of the tongue, chin and tongue of the neck of the human body;
the detection device is used for collecting photoplethysmography signals when a human body is in a sleep state and generating electrical stimulation driving signals based on the treatment threshold range of the photoplethysmography signals;
the treatment device is coupled with the detection device and releases the Lilly waveform to electrically stimulate the hypoglossal nerve branch innervating the genioglossus muscle after receiving the electric stimulation driving signal.
Further, the detection device comprises a controller, an infrared sensor and a photosensitive element; the controller is respectively electrically connected with the infrared sensor and the photosensitive element;
the controller controls the infrared sensor to emit near infrared light, and the near infrared light is emitted to the outer part of the neck, the chin, the tongue muscle and the skin in a non-invasive mode;
the controller controls the photosensitive element to absorb infrared light energy and records the change rule of the light energy so as to realize the acquisition of photoplethysmography signals.
Furthermore, the controller also comprises a microprocessor, an inverter and a filtering component;
the filtering component is respectively and electrically connected with the phase inverter and the microprocessor;
the phase inversion processing is carried out on the photoplethysmography signals through the phase inverter;
passing photoplethysmographic signals through the filtering component according to a preset treatment threshold range;
and the microprocessor sends out an electrical stimulation driving signal according to the photoplethysmogram signal of the filtering component after the phase inversion processing.
Further, the filtering component comprises a low-pass filter and a band-pass filter;
screening the photoplethysmography signals of a low-frequency threshold value through the low-pass filter;
and screening the photoplethysmographic signals within a threshold range through the band-pass filter.
Further, the controller further comprises an A/D converter, a data memory and a clock synchronizer;
the microprocessor is electrically connected with the A/D converter, the data memory and the clock synchronizer respectively;
the A/D converter is used for converting the photoplethysmography signals after the phase inversion processing into photoplethysmography data;
the data memory is used for storing the detection and treatment actions of the photoelectric volume pulse wave data;
the clock synchronization device is used for synchronizing time with the terminal equipment and naming the stored detection and treatment of the photoplethysmography data by utilizing the time.
Further, the controller also comprises a data transmitter which is electrically connected with the microprocessor, and the data transmitter outputs the detection and treatment of the processed photoplethysmography data and receives a threshold range set by the terminal device for generating the electrical stimulation driving signal.
Further, the data transmitter adopts a data transmission interface and/or a wireless transceiver to transmit and transmit data to the terminal device in a wired and/or wireless mode.
Further, the patch body adopts a double-sided interlayer structure.
Furthermore, this internal conducting film that is equipped with of paster, the conducting film adopts the PU material, through conducting film conduction electro photoluminescence signal.
Furthermore, the patch body is provided with an adhesive surface, two sides of the adhesive surface are provided with adhesive sheets, and the adhesive sheets are adhered to the outer part of the skin of the chin and the genioglossus of the neck of the human body in a contact manner.
The patch type OSAHS detection and treatment device provided by the embodiment of the application at least has the following technical effects:
1, because the Lilly waveform, namely the charge-balanced bidirectional stimulation waveform, is adopted, the muscle tissue damage is effectively reduced, even the tissue damage can be completely avoided, and the Lilly waveform is particularly effective for the tissues which are often subjected to electric stimulation.
2, because of adopting the percutaneous genioglossus muscle electrical stimulation therapy, make it have advantages such as small, light in weight, easy operation convenience, make the compliance of using crowd high, it is wider to be suitable for the crowd, solved the uncomfortable of existing treatment scheme in market simultaneously, potential side effect, inconvenient operation scheduling problem, and compare in invasive treatment, this application is based on the conservative treatment of non-invasive, more caters to the treatment psychology of Chinese patient.
Clinical studies show that compared with the prior stimulation, the electrical stimulation can immediately reduce apnea and hypopnea events, the Sp02 is obviously improved, no obvious adverse reaction exists in treatment, and no venous reflux disorder exists at the head and the neck. Moreover, clinical studies show that the stimulation of the genioglossus muscle through the sublingual vein is minimally invasive, does not need to separate nerves or damage the nerves, can be used for a long time, and has better OSAHS treatment prospect.
4, because when carrying out the electro photoluminescence to the genioglossus muscle, possess the collection effect to photoplethysmography PPG signal characteristic for utilize as little information as possible, fully excavate in the limited monitoring signal and the sleep in-process relevant information, and then can treat the aassessment to the sleep overall process.
Drawings
Fig. 1 is a block diagram of a patch-type OSAHS detection and treatment apparatus in an embodiment of the present application;
fig. 2 is a block diagram illustrating a control detection structure of the detection device in the embodiment of the present application;
FIG. 3 is a block diagram of a controller controlling a therapy according to an embodiment of the present application;
fig. 4 is a block diagram of a control data transmission of a controller according to an embodiment of the present disclosure;
FIG. 5 is a schematic structural view of an adhesive surface of a patch body according to an embodiment of the present disclosure;
fig. 6 is a schematic structural view of the operation surface of the patch body in the embodiment of the present application.
Reference numerals:
the device comprises a detection device 100, a controller 110, an infrared sensor 120, a photosensitive element 130, a microprocessor 111, an inverter 112, a filter assembly 113, a low-pass filter 113a, a band-pass filter 113b, an A/D converter 114, a data memory 115, a clock synchronizer 116, a data transmitter 117, a treatment device 200, a patch body 300, an adhesive surface 320, an adhesive sheet 321, a data transmission interface 330 and a switch 340.
Detailed Description
In order to better understand the technical solution, the technical solution will be described in detail with reference to the drawings and the specific embodiments.
Referring to fig. 1, the present embodiment provides a patch-type OSAHS detection treatment apparatus 200, including: the patch comprises a patch body 300, wherein the inner side of the patch body 300 is provided with a detection device 100 and a treatment device 200. The patch body 300 is adhered to the outer skin of the chin and genioglossus of the neck of a human body. The detection device 100 is configured to collect a photoplethysmography signal when a human body is in a sleep state, and generate an electrical stimulation driving signal based on a treatment threshold range of the photoplethysmography signal. The treatment device 200 is coupled with the detection device 100, and after receiving the electrical stimulation driving signal, releases the Lilly waveform to electrically stimulate the hypoglossal nerve branch innervating the genioglossus muscle.
The working principle of the Lilly waveform adopted in the embodiment to electrically stimulate the hypoglossal nerve branch innervating the genioglossus muscle is as follows: the Lilly waveform is composed of positive and negative bidirectional current pulse waves with equal charges, and a delay time is arranged between the positive and negative pulses. The first negative pulse wave acts to depolarize the nerve fibers, and the second exponentially decaying pulse acts to balance the charge so that the net charge taken up by the electrical stimulus is zero. The inventor of the application finds that the nerve is stimulated by adopting the unidirectional negative pulse wave, the injury of the peripheral muscle tissue can be caused, the injury of the muscle tissue can be reduced by adopting the charge-balanced bidirectional stimulation waveform, the tissue injury can be even completely avoided, and the nerve stimulation waveform is particularly effective to the tissue which is often subjected to electric stimulation.
Furthermore, the response of nerve cells to the electrical stimulation is utilized in the electrical stimulation to conduct an external artificial control signal, the nerve cells can generate a nerve pulse which is completely the same as action potential caused by natural excitation through the action of external current, muscle fibers dominated by the nerve pulses shrink, and upper airway dilator mainly comprising genioglossus muscle enables a tongue body to move forwards to enlarge a glossopharyngeal airway, so that the upper airway resistance is reduced, the hypoxemia at night is improved, the sleep structure is improved, and the treatment purpose is achieved.
It can be concluded that the principle of using patch-type detection therapy in this embodiment is as follows: through the external patch, the genioglossus muscle is electrically stimulated through skin, so that the number of times of apnea of an OSAHS patient is reduced, the blood oxygen saturation is improved, and the symptoms are improved; the electrical stimulation produced acts to stimulate the electrical excitability of the nerve cells. The electrical excitability of nerve cells is derived from the fact that cell membranes have different permeability to sodium ions, potassium ions and chloride ions, the resting potential of cells is determined by the ion concentration inside and outside the cells during balancing, and after the nerve cells are electrically stimulated, the permeability of the cell membranes to the ions changes, so that the membrane potential is mutated to form an action potential.
The detecting device 100 in this embodiment includes a controller 110, an infrared sensor 120, and a photosensitive element 130. The controller 110 is electrically connected with the infrared sensor 120 and the photosensitive element 130 respectively; the controller 110 controls the infrared sensor 120 to emit near-infrared light to the outside of the skin of the chin and genioglossus muscle of the neck in a non-invasive manner. The controller 110 controls the photosensitive element 130 to absorb infrared light energy and records the change rule of the light energy, thereby realizing the collection of the photoplethysmography pulse signals. In the embodiment, in order to utilize information as little as possible, the whole sleep process can be evaluated by fully mining relevant information in the limited monitoring signals and the sleep process. The adopted photoplethysmography (PPG) signal is a signal which utilizes a non-invasive technology to drive near infrared light into skin, and then light energy is absorbed by a photosensitive component to record the change of the light energy. In this embodiment, when the heart contracts and expands, the artery also contracts and expands along with the heart, so that the blood flow of the unit area in the blood vessel changes periodically; when the blood volume changes, the light sensed by the light sensing component also changes along with the change of the blood volume. The amplitude of the obtained photoplethysmographic signal is proportional to the change in the blood flow into and out of the tissue and is considered as an alternating component. The off-signal waveform, which changes with time, tissue changes, is called a signal, and thus can be used to analyze cardiovascular parameters.
In addition, a switch 340 is further provided in this embodiment, the switch 340 is electrically connected to the controller 110, and the switch 340 controls the start of the detection apparatus 100. The present embodiment further includes a power supply, which is connected to the controller 110 to provide power for the operation of the whole device.
The controller 110 in this embodiment further includes a microprocessor 111, an inverter 112, and a filter assembly 113. The filter assembly 113 is electrically connected to the inverter 112 and the microprocessor 111, respectively; inverting the photoplethysmographic signal through the inverter 112; passing photoplethysmographic signals through the filtering component 113 according to a preset treatment threshold range; the microprocessor 111 sends out an electrical stimulation driving signal according to the photoplethysmogram signal processed in opposite phase and passing through the filtering component 113. In one embodiment, filtering component 113 includes a low pass filter 113a, a band pass filter 113 b; screening the photoplethysmographic signals of a low-frequency threshold value through the low-pass filter 113 a; the photoplethysmographic signals within a threshold range are filtered by the band pass filter 113 b. It is understood that the low pass filter 113a and the band pass filter 113b are respectively connected to the controller 110; the low-pass filter 113a is used to pass the photoplethysmographic signal of the low frequency threshold; the band-pass filter 113b is used to pass the photoplethysmographic signal within a threshold range; the controller 110 generates an electrical stimulation driving signal according to the photoplethysmographic signal through the low pass filter 113a or the band pass filter 113 b. In one embodiment, the cut-off frequency of the low pass filter 113a is 1Hz, which is due to the fact that the person is asleep in the range of 10-44 breaths per minute, and the differential pressure signal of the channel is used for detecting apnea; the pass band frequency of the band pass filter 113b is 0.1-10Hz and the channel signal is used to detect an occlusion in order to filter out air leakage conditions and high frequency noise frequencies.
The controller 110 in this embodiment further includes a data memory 115 and a clock synchronizer 116; the microprocessor 111 is electrically connected to the a/D converter 114, the data storage 115, and the clock synchronizer 116, respectively; in this embodiment, the microprocessor 111 is used to control the detection and treatment of the photoplethysmography signals of the human body in the sleep state, and the a/D converter 114 is used to convert the photoplethysmography signals after the phase inversion processing into photoplethysmography data; the data storage 115 is used for storing the detection and treatment actions of the photoplethysmography data; the clock synchronization device is used for synchronizing time with the terminal equipment and naming the stored detection and treatment of the photoplethysmography data by utilizing the time.
The detection device 100 in this embodiment further includes a data transmitter 117, the data transmitter 117 is electrically connected to the microprocessor 111, and the data transmitter 117 outputs the detection and treatment of the processed photoplethysmography data, and receives a threshold range set by the terminal device for generating the electrical stimulation driving signal. In one embodiment, the data transmitter 117 employs the data transmission interface 330 and/or a wireless transceiver to transmit and transmit data to the terminal device in a wired and/or wireless manner. The data transmission interface 330 is disposed on the surface of the operation surface of the patch body. The data transmission interface transmits data through a data line, the data transmission interface can be any one of common data interfaces, such as a Micro-USB interface, a USB Type-C interface, and the like, and the external data line is used to derive the detection and treatment actions of the photoplethysmography data stored in the data memory 115. The wireless transceiver can be one of a radio frequency transceiver, a bluetooth transceiver or other common wireless transceivers, and can transmit the sleep data to the terminal device in real time, so that the terminal device can perform identification diagnosis and data mining on the sleep data, thereby realizing preliminary diagnosis, displaying a diagnosis result and sending the diagnosis result.
The terminal device in this embodiment may be understood as a terminal device connected to the cloud big data platform, and may be a commonly-used terminal device such as a notebook, a mobile phone, and a tablet. The terminal equipment receives the detection and treatment actions of the photoplethysmography data sent in real time in the acquisition state in the home network. Further, the detection and treatment actions of the photoplethysmography data are uploaded to a medical platform, so that a patient database similar to a snore database is established for a patient, and related diagnosis bases are provided for the patient when the patient is subjected to a special medical visit by utilizing network remote interaction, so that internet medical treatment is realized, and meanwhile, a big data service is provided for scientific decisions of scientific research institutions and supervision departments. In the embodiment, a medical big data platform is established based on a medical data center of the company by utilizing an internet technology and a big data technology. In this embodiment, a Hadoop technology is used to store and mine data of the patch-type OSAHS detection and treatment apparatus 200 in this embodiment. Training an artificial intelligent learning model by using machine learning; the outcome of machine learning can be verified and predicted through a medical big data platform. Reasonable clinical suggestions are given to the user by means of a large data platform. A large amount of clinical data can be used in the medical database to accurately search the pathogenic causes of OSAHS, provide a scientific treatment scheme and promote personalized accurate treatment.
The patch body 300 in this embodiment adopts a double-sided sandwich structure. In one embodiment, the patch body 300 is provided with a conductive film made of PU, and the conductive film conducts the electrical stimulation signal. The patch body 300 is provided with an adhesive surface 320, two sides of the adhesive surface 320 are provided with adhesive sheets 321, and the adhesive sheets 321 are contacted and adhered to the outer part of the skin of the chin and the genioglossus of the neck of the human body. In one embodiment, the patch body 300 has a rectangular double-sided interlayer with a length of 15cm and a width of 7cm, and is made of mesh cloth, an inner core is made of cotton cloth, and a conductive film made of PU is arranged on the inner core, so that when an electrical stimulation signal is generated, electrical stimulation is conducted to the outer part of the skin of the chin, chin and tongue of the neck through the conductive film. In one embodiment, the adhesive surface 320 contacts human skin, and has adhesive pieces 321 with a length of 7cm and a width of 1cm on the left and right sides, and when in use, the switch 340 on the patch main body is firstly opened, the oil surface of the adhesive pieces 321 is taken down, and the central part of the patch main body is aligned to the outer part of the skin of the chin-tongue of the neck and is attached.
In summary, the patch-type OSAHS detection and treatment device 200 in the embodiment adopts a charge-balanced dual-stimulation Lilly waveform, so that the muscle tissue damage is effectively reduced; the percutaneous submental tongue myoelectricity stimulation therapy is combined, so that the percutaneous submental tongue myoelectricity stimulation therapy has the advantages of small size, light weight, simplicity and convenience in operation and the like, the dependence of users is high, the applicable population is wider, the problems of discomfort, potential side effects, inconvenience in operation and the like of the existing treatment scheme in the market are solved, and compared with the operation type invasive therapy, the conservative therapy adopted in the embodiment is more suitable for the treatment psychology of patients. Clinical studies of the inventor show that compared with the prior stimulation, the electrical stimulation can obviously reduce apnea and hypopnea events immediately, Sp02 is obviously improved, no obvious adverse reaction exists in treatment, and no venous reflux disorder exists in the head and neck. Clinical studies show that stimulation of the genioglossus muscle via the sublingual vein in this embodiment is minimally invasive, does not need to separate nerves, does not damage nerves, can be used for a long time, and has a high prospect for treatment of OSAHS. This embodiment carries out the electro photoluminescence to the genioglossus muscle, possesses the collection effect to photoplethysmography PPG signal characteristic, utilizes as little information as possible, through fully excavating in the limited monitoring signal with the sleep in-process relevant information, and then can assess the sleep overall process.
While the preferred embodiments of the present invention have been described, additional variations and modifications in those embodiments may occur to those skilled in the art once they learn of the basic inventive concepts. It is therefore intended that the appended claims be interpreted as including the preferred embodiment and all such alterations and modifications as fall within the scope of the invention.
It will be apparent to those skilled in the art that various changes and modifications may be made to the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims and their equivalents, the present invention is also intended to include such modifications and variations.
Claims (10)
1. The utility model provides a SMD OSAHS detects treatment device which characterized in that includes: the patch comprises a patch body, wherein a detection device and a treatment device are arranged on the inner side of the patch body;
the patch body is stuck to the outer part of the skin of the tongue, chin and tongue of the neck of the human body;
the detection device is used for collecting photoplethysmography signals when a human body is in a sleep state and generating electrical stimulation driving signals based on the treatment threshold range of the photoplethysmography signals;
the treatment device is coupled with the detection device and releases the Lilly waveform to electrically stimulate the hypoglossal nerve branch innervating the genioglossus muscle after receiving the electric stimulation driving signal.
2. The patch-style OSAHS detection therapy device according to claim 1, wherein the detection device comprises a controller, an infrared sensor, a light sensing element; the controller is respectively electrically connected with the infrared sensor and the photosensitive element;
the controller controls the infrared sensor to emit near infrared light, and the near infrared light is emitted to the outer part of the neck, the chin, the tongue muscle and the skin in a non-invasive mode;
the controller controls the photosensitive element to absorb infrared light energy and records the change rule of the light energy so as to realize the acquisition of photoplethysmography signals.
3. The patch OSAHS detection therapy apparatus of claim 2 wherein the controller further comprises a microprocessor, an inverter, a filter assembly;
the filtering component is respectively and electrically connected with the phase inverter and the microprocessor;
the phase inversion processing is carried out on the photoplethysmography signals through the phase inverter;
passing photoplethysmographic signals through the filtering component according to a preset treatment threshold range;
and the microprocessor sends out an electrical stimulation driving signal according to the photoplethysmogram signal of the filtering component after the phase inversion processing.
4. The patch based OSAHS detection therapy device of claim 3, wherein the filtering component comprises a low pass filter, a band pass filter;
screening the photoplethysmography signals of a low-frequency threshold value through the low-pass filter;
and screening the photoplethysmographic signals within a threshold range through the band-pass filter.
5. The SMD OSAHS detection treatment apparatus of claim 3, wherein said controller further comprises an A/D converter, a data memory and a clock synchronizer;
the microprocessor is electrically connected with the A/D converter, the data memory and the clock synchronizer respectively;
the A/D converter is used for converting the photoplethysmography signals after the phase inversion processing into photoplethysmography data;
the data memory is used for storing the detection and treatment actions of the photoelectric volume pulse wave data;
the clock synchronization device is used for synchronizing time with the terminal equipment and naming the stored detection and treatment of the photoplethysmography data by utilizing the time.
6. The patch-type OSAHS detection therapy apparatus according to claim 3, wherein the controller further comprises a data transmitter electrically connected to the microprocessor, and the data transmitter outputs the detection and therapy of the processed photoplethysmography data, and receives a threshold range set by a terminal device for generating the electrical stimulation driving signal.
7. The SMD OSAHS detection treatment apparatus of claim 6, wherein said data transmitter employs a data transmission interface and/or a wireless transceiver for transmitting data to a terminal device in a wired and/or wireless manner.
8. The patch-type OSAHS detection treatment apparatus of claim 1, wherein the patch body is of a double-sided sandwich structure.
9. The patch-type OSAHS detection and treatment device according to claim 8, wherein a conductive film is provided in the patch body, and PU material is adopted, and the conductive film is used for conducting electrical stimulation signals.
10. The patch-type OSAHS detection and treatment device according to claim 8, wherein the patch body is provided with an adhesive surface, and adhesive sheets are arranged on two sides of the adhesive surface and are adhered to the outer part of the skin of the human neck under the tongue and chin and tongue through contact of the adhesive sheets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202022828389.2U CN215128552U (en) | 2020-11-30 | 2020-11-30 | SMD OSAHS detects treatment device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202022828389.2U CN215128552U (en) | 2020-11-30 | 2020-11-30 | SMD OSAHS detects treatment device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN215128552U true CN215128552U (en) | 2021-12-14 |
Family
ID=79350921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202022828389.2U Expired - Fee Related CN215128552U (en) | 2020-11-30 | 2020-11-30 | SMD OSAHS detects treatment device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN215128552U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114159032A (en) * | 2021-12-23 | 2022-03-11 | 山东领能电子科技有限公司 | Sleep apnea monitoring device and method based on temperature and humidity sensor |
-
2020
- 2020-11-30 CN CN202022828389.2U patent/CN215128552U/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114159032A (en) * | 2021-12-23 | 2022-03-11 | 山东领能电子科技有限公司 | Sleep apnea monitoring device and method based on temperature and humidity sensor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200282215A1 (en) | Evaluating stimulation eficacy for treating sleep apnea and lingual muscle tone sensing system for improved osa therapy | |
| EP1938862B1 (en) | Disordered breathing management system and methods | |
| CN101495178B (en) | Method and apparatus for hypoglossal nerve stimulation | |
| EP1670547B1 (en) | Patient monitoring system | |
| CN111938576B (en) | Sleep physiological warning system | |
| US20140135868A1 (en) | Non-invasive intraoral electrical stimulator system and method for treatment of obstructive sleep apnea (osa) | |
| US20050080461A1 (en) | System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep | |
| CN107205693A (en) | It is a kind of to detect, assess and treatment snoring, sleep apnea and the not enough device of sleep-respiratory | |
| CN106943673A (en) | A kind of sleep apnea monitoring treatment system | |
| CN110353874B (en) | Sleep disordered breathing treatment system | |
| WO2003092493A2 (en) | Implantable apnea monitor | |
| US11058349B2 (en) | Non-invasive handling of sleep apnea, snoring and emergency situations | |
| TWM599629U (en) | Sleep physiological system | |
| CN215128552U (en) | SMD OSAHS detects treatment device | |
| CN110584626A (en) | Head-mounted snore monitoring device and snore stopping method | |
| CN206453760U (en) | A kind of sleep monitor system | |
| CN108888240A (en) | A kind of sleep monitor and improve device and its system | |
| CN106669031B (en) | Snore symptom sleep apnea preventing system | |
| CN207356076U (en) | A kind of intelligent sleep monitor | |
| CN106669032B (en) | Snore sleep apnea preventing system capable of being charged rapidly | |
| CN114903448A (en) | Sleep respiration monitoring device and sleep respiration monitoring method | |
| CN209285515U (en) | A kind of pause syndrome training of medical respiration and therapeutic equipment | |
| CN210843738U (en) | Snore stopping equipment | |
| CN209269662U (en) | A kind of sleep monitor and improve device and its system | |
| CN106726090B (en) | Rechargeable snoring sleep apnea prevention system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20211214 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |